What is the origin of MTM, which is popular with capital

MTM is a blockchain project jointly built by the tally foundation, which is invested by the famous American investment company tally capital. Tally foundation, located in Chicago, USA, was founded in 2008 with abundant capital. It has a wide range of business, covering many fields, such as medicine, education, architecture, entertainment and so on


MTM is a team composed of high-end researchers, professional medical professionals, dedicated investors and innovative engineers to create a unique platform. MTM is an important application scenario based on blockchain technology to solve stem cell traceability and other medical industries. It will eventually be built into a low-level development service platform in blockchain, such as Google Android and apple IOS, to support the extended development and efficient operation of dapps, and build an application ecosystem based on blockchain.


At present, MTM has reached a strategic cooperation with Ukrainian medical stem cell transplantation center. MTM will provide the underlying technology application of blockchain for Ukrainian National Medical embryonic stem cell center. At the same time, Ukrainian National Medical embryonic stem cell center has also joined MTM's ecological autonomous region. At present, Ukrainian National Medical embryonic stem cell center is also the only one in the world that supports MTM As one of the application scenarios of economic circulation, Ukrainian National Medical embryonic stem cell center not only creates the application scenario of MTM, but also provides more convenient and faster services for users of global ecological community.


The national medical embryonic stem cell center of Ukraine has been pushed to the forefront of international high-tech medical treatment due to the Chernobyl nuclear leakage of the Soviet Union which shocked the world in 1986. Since then, the national medical embryonic stem cell center of Ukraine has joined hands with almost all the authoritative medical science experts, hospitals and research institutes in Ukraine to provide high-end medical solutions for patients from all over the world, and launched the ultimate challenge to the incurable disease of human beings - to start the research and treatment of embryonic stem cell transplantation!


The picture shows the patents and certificates obtained by Ukrainian medical stem cell transplantation center


Emcell cell center medical practice license


License to use stem cells


Patents for diabetes treatment


Patent certificate of stem cell therapy


Embryonic stem cells for chronic heart failure


Embryonic stem cell comprehensive medical patent for hypertension


Embryonic stem cell cancer treatment patents


Embryonic stem cell medical multiple sclerosis certificate patent


Anti aging treatment patent


Patent of embryo therapy for autism


Treatment of Parkinson's syndrome with embryonic stem cells:


Patent of comprehensive treatment of erectile dysfunction with embryonic stem cells


MTM combines blockchain, the most important underlying technology in the future, with stem cell, the most important social technology in the future. It can release great commercial and social value, and has unlimited imagination space for application scenarios. From collection to storage, from research and development to application, MTM is deeply involved in stem cells, and master the core technology. MTM adheres to the mission of promoting the development of global health, is committed to serving the National People's livelihood, and is committed to improving human health.



Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.
©copyright 2009-2020 Rubric News      Contact Us   SiteMap